(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S.

Ms. Starrett brings over 25 years of commercial, product, and operations experience at data and technology companies, and a ...

Haier Biomedical (688139.SH), a global leader in life sciences and medical solutions, is making simultaneous presence at ...

The U.S. Laboratory Developed Tests Market is projected to grow from USD 5.97 Billion in 2025 to USD 11.85 Billion by 2035, while Europe is expected to expand from USD 3.75 Billion to USD 7.55 Billion ...

(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of $275 million aggregate ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today that it has commenced a private offering of $275 million aggregate ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences: ...

FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $9.9 million in its fourth quarter. The Fort Myers, Florida-based company said it had a loss of 8 ...

NeoGenomics Inc. company and executive profile by Barron's. View the latest NEO company infomation and executive bios.